Complete Echo-endoscopic staging of lung cancer vs mediastinoscopy: a randomised clinical trial.

Complete Echo-endoscopic staging of lung cancer vs mediastinoscopy: a randomised clinical trial. - Echo-endoscopic versus surgical staging of lung cancer.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30291

Enrollment

Registered

2007-02-01

Start date

2007-01-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial malignancy lung cancer

Interventions

Echo - endoscopic staging consisting of an combination of transesophageal ultrasound guided fine needle aspiration (EUS-FNA) and transbronchial ultrasound guided needle aspuiration (EBUS-TBNA) of me

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Those patients with (suspected) non small cell lung cancer that are candidates for surgical resction of the lung tumor in whom- according to the national CBO guideline - there is an indication to obtain tissue from the mediastinal lymph nodes.

Exclusion criteria

Exclusion criteria: Prior chemo/ or radiation therapy for lung cancer Esophageal strictures Concurrent other malignant diseases

Design outcomes

Primary

Measure	Time frame
Decetion of regional lymph node metastases	—

Secondary

Measure	Time frame
Detection of tumour invasion Complications Costs Futile thoracotomies in both study arms	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)